De la Torre entered medicine with high ideals and unstoppable ambition. His talent and drive bowled over just about everyone he worked with, and his rise to power and eminence seemed inexorable.
Many in the health care industry were unwilling to speak on the record about de la Torre, but in a dozen interviews, some blamed the company's flagging finances on greed. And some are taking particular aim at de la Torre, including those who helped propel his career.
Brown to fund four biomedical technologies with potential for patient benefit, commercial viability indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
By Noel Rubinton, Communications Manager, Office of the Vice President for Research
Now in its third funding cycle, Brown Biomedical Innovations to Impact will award four faculty projects to accelerate promising medical solutions into commercial technologies.
PROVIDENCE, R.I. [Brown University] – Four teams of Brown University researchers have been awarded up to $100,000 each to accelerate the translation of their scientific discoveries into commercial products that could benefit patients facing urgent medical challenges. Projects range from treating a rare childhood genetic disease to finding a new way to combat a deadly cancer.
In its third annual award cycle, Brown Biomedical Innovations to Impact (BBII) also supported research that aims to allow better collaboration in surgery and to grow human tissues for use in patients after heart attacks.
Brown to fund four biomedical technologies with potential for patient benefit, commercial viability brown.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from brown.edu Daily Mail and Mail on Sunday newspapers.